Analystreport

Trillium Therapeutics Inc (NASDAQ: TRIL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Defiance Trillion Dollar Club Index ETF  (TRIL) 
Last defiance trillion dollar club index etf earnings: 5/13 07:00 am Check Earnings Report